Metformin Hydrochloride Milpharm

Metformin, the active ingredient in Metformin Hydrochloride Milpharm, is a biguanide presented as an oral tablet for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity.

GNH USA supplies Metformin Hydrochloride Milpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements across EU markets.

Metformin is a biguanide antidiabetic that lowers blood glucose primarily in type 2 diabetes.

- Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes. - Polycystic ovary syndrome: reduces insulin resistance and may improve menstrual regularity.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often transient. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic complication. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: marked elevation of liver enzymes. - Hypoglycemia: uncommon when used alone, but possible with concomitant agents. - Pancreatitis: inflammation of the pancreas. - Anemia: rare reduction in red blood cell count.

Metformin requires careful patient assessment and monitoring.

- Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic disease: avoid in patients with severe liver impairment. - Alcohol consumption: limit intake to reduce risk of lactic acidosis. - Pregnancy: generally contraindicated unless benefits outweigh potential risks. - Vitamin B12 monitoring: consider periodic assessment for deficiency. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with several medicines, requiring dose adjustment or monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: may raise plasma metformin concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics (thiazides): can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes.